A citation-based method for searching scientific literature

Priyanka Sharma, Roisin M Connolly, Evanthia T Roussos Torres, Alastair Thompson. Am Soc Clin Oncol Educ Book 2020
Times Cited: 6







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Targeting PML in triple negative breast cancer elicits growth suppression and senescence.
Leire Arreal, Marco Piva, Sonia Fernández, Ajinkya Revandkar, Ariane Schaub-Clerigué, Josep Villanueva, Amaia Zabala-Letona, Mikel Pujana, Ianire Astobiza, Ana Rosa Cortazar,[...]. Cell Death Differ 2020
12
16

Molecular characterization of breast cancer cell lines through multiple omic approaches.
Shari E Smith, Paul Mellor, Alison K Ward, Stephanie Kendall, Megan McDonald, Frederick S Vizeacoumar, Franco J Vizeacoumar, Scott Napper, Deborah H Anderson. Breast Cancer Res 2017
45
16

Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition.
Hongbiao Huang, Ni Liu, Yuning Liao, Ningning Liu, Jianyu Cai, Xiaohong Xia, Zhiqiang Guo, Yanling Li, Qirong Wen, Qi Yin,[...]. J Exp Clin Cancer Res 2017
15
16

A bird's eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer.
Nilesh Malavia, Kaushik Kuche, Rohan Ghadi, Sanyog Jain. J Control Release 2021
6
16

Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis.
J R Dev Arundhathi, Sandeep R Mathur, Ajay Gogia, S V S Deo, Purusottam Mohapatra, Chandra Prakash Prasad. Mol Biol Rep 2021
8
16


A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.
Richard W Ahn, Feng Chen, Haimei Chen, Stephan T Stern, Jeffrey D Clogston, Anil K Patri, Meera R Raja, Elden P Swindell, Vamsi Parimi, Vincent L Cryns,[...]. Clin Cancer Res 2010
79
16

PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer.
Andrä Brunner, Aldwin Suryo Rahmanto, Henrik Johansson, Marcela Franco, Johanna Viiliäinen, Mohiuddin Gazi, Oliver Frings, Erik Fredlund, Charles Spruck, Janne Lehtiö,[...]. Elife 2020
10
16


Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer.
Xing Xin, Ti Wen, Li-Bao Gong, Ming-Ming Deng, Ke-Zuo Hou, Lu Xu, Sha Shi, Xiu-Juan Qu, Yun-Peng Liu, Xiao-Fang Che,[...]. Front Oncol 2020
6
16


Synthetic methods for the preparation of platinum anticancer complexes.
Justin J Wilson, Stephen J Lippard. Chem Rev 2014
264
16

The Effects on Angiogenesis of Relevant Inorganic Chemotherapeutics.
Tiziano Marzo, Diego La Mendola. Curr Top Med Chem 2021
4
25


Robust structure and reactivity of aqueous arsenous acid-platinum(II) anticancer complexes.
Đenana U Miodragović, Jeremy A Quentzel, Josh W Kurutz, Charlotte L Stern, Richard W Ahn, Irawati Kandela, Andrew Mazar, Thomas V O'Halloran. Angew Chem Int Ed Engl 2013
30
16

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Solene De Talhouet, Julien Peron, Aurelie Vuilleumier, Alex Friedlaender, Valeria Viassolo, Aurélie Ayme, Alexandre Bodmer, Isabelle Treilleux, Noemie Lang, Jean- Christophe Tille,[...]. Sci Rep 2020
33
16

A first-in-class and a fished out anticancer platinum compound: cis-[PtCl2(NH3)2] and cis-[PtI2(NH3)2] compared for their reactivity towards DNA model systems.
Domenica Musumeci, Chiara Platella, Claudia Riccardi, Antonello Merlino, Tiziano Marzo, Lara Massai, Luigi Messori, Daniela Montesarchio. Dalton Trans 2016
23
16

Hydrogen bonding, solvation, and hydrolysis of cisplatin: a theoretical study.
Arturo Robertazzi, James A Platts. J Comput Chem 2004
47
16

Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?
Xupeng Bai, Jie Ni, Julia Beretov, Peter Graham, Yong Li. Cancer Lett 2021
19
16

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going.
Claudia Omarini, Giorgia Guaitoli, Stefania Pipitone, Luca Moscetti, Laura Cortesi, Stefano Cascinu, Federico Piacentini. Cancer Manag Res 2018
44
16

Beyond Cisplatin: Combination Therapy with Arsenic Trioxide.
Ðenana Miodragović, Elden P Swindell, Zohra Sattar Waxali, Abraham Bogachkov, Thomas V O'Halloran. Inorganica Chim Acta 2019
11
16

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research.
Jose Rodrigo Espinosa Fernandez, Bedrich L Eckhardt, Jangsoon Lee, Bora Lim, Troy Pearson, Rob S Seitz, David R Hout, Brock L Schweitzer, Tyler J Nielsen, O Rayne Lawrence,[...]. PLoS One 2020
9
16

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
Melinda L Telli, Kirsten M Timms, Julia Reid, Bryan Hennessy, Gordon B Mills, Kristin C Jensen, Zoltan Szallasi, William T Barry, Eric P Winer, Nadine M Tung,[...]. Clin Cancer Res 2016
444
16

RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence.
Brittany Haynes, Ambikai Gajan, Pratima Nangia-Makker, Malathy P Shekhar. Biochim Biophys Acta Mol Basis Dis 2020
11
16

Reactions of cisplatin and glycine in solution with constant pH: a computational study.
Luděk Michera, Michaela Nekadová, Jaroslav V Burda. Phys Chem Chem Phys 2012
5
20


A short history of SHELX.
George M Sheldrick. Acta Crystallogr A 2008
16


PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes.
Manfredi Ponente, Letizia Campanini, Roberto Cuttano, Andrea Piunti, Giacomo A Delledonne, Nadia Coltella, Roberta Valsecchi, Alessandra Villa, Ugo Cavallaro, Linda Pattini,[...]. JCI Insight 2017
27
16

Quantum mechanical and spectroscopic (FT-IR, 13C, 1H NMR and UV) investigations of potent antiepileptic drug 1-(4-chloro-phenyl)-3-phenyl-succinimide.
Vesna D Vitnik, Željko J Vitnik, Nebojša R Banjac, Nataša V Valentić, Gordana S Ušćumlić, Ivan O Juranić. Spectrochim Acta A Mol Biomol Spectrosc 2014
7
16




An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity.
Nicole L Moore, Grant Buchanan, Jonathan M Harris, Luke A Selth, Tina Bianco-Miotto, Adrienne R Hanson, Stephen N Birrell, Lisa M Butler, Theresa E Hickey, Wayne D Tilley. Endocr Relat Cancer 2012
37
16


Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro.
Natalia Miklášová, Eva Fischer-Fodor, Peter Lönnecke, Ciprian Ionuţ Tomuleasa, Piroska Virag, Maria Perde Schrepler, Roman Mikláš, Luminiţa Silaghi Dumitrescu, Evamarie Hey-Hawkins. Eur J Med Chem 2012
28
16

Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells.
Ying Qu, Bingchen Han, Yi Yu, Weiwu Yao, Shikha Bose, Beth Y Karlan, Armando E Giuliano, Xiaojiang Cui. PLoS One 2015
109
16

Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent.
Đenana Miodragović, Antonello Merlino, Elden P Swindell, Abraham Bogachkov, Richard W Ahn, Sara Abuhadba, Giarita Ferraro, Tiziano Marzo, Andrew P Mazar, Luigi Messori,[...]. J Am Chem Soc 2019
25
16

Construction of arsenic-metal complexes loaded nanodrugs for solid tumor therapy: A mini review.
Weidong Fei, Chaoqun Li, Jiaoyang Tao, Xinjun Cai, Wendong Yao, Yiqing Ye, Yue Zhang, Yao Yao, Qianqian Song, Fanzhu Li,[...]. Int J Pharm 2020
9
16

On the hydrolysis mechanism of the second-generation anticancer drug carboplatin.
Matej Pavelka, Maria Fatima A Lucas, Nino Russo. Chemistry 2007
63
16

cis-Pt I2(NH3)2: a reappraisal.
Tiziano Marzo, Serena Pillozzi, Ondrej Hrabina, Jana Kasparkova, Viktor Brabec, Annarosa Arcangeli, Gianluca Bartoli, Mirko Severi, Alessandro Lunghi, Federico Totti,[...]. Dalton Trans 2015
33
16

The trans effect in square-planar platinum(II) complexes--a density functional study.
Zdenek Chval, Miroslav Sip, Jaroslav V Burda. J Comput Chem 2008
32
16

The second-generation anticancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism.
Marta E Alberto, Maria Fatima A Lucas, Matej Pavelka, Nino Russo. J Phys Chem B 2009
43
16

Organic vapor triggered repeatable on-off crystalline-state luminescence switching.
Kensuke Naka, Takuji Kato, Seiji Watase, Kimihiro Matsukawa. Inorg Chem 2012
16
16

Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo.
Richard W Ahn, Susan L Barrett, Meera R Raja, Jennifer K Jozefik, Lidia Spaho, Haimei Chen, Marcel B Bally, Andrew P Mazar, Michael J Avram, Jane N Winter,[...]. PLoS One 2013
41
16

Delivery of Arsenic Trioxide by Multifunction Nanoparticles To Improve the Treatment of Hepatocellular Carcinoma.
Qirun Wu, Xiaowei Chen, Peng Wang, Qiong Wu, Xun Qi, Xiangjun Han, Lufeng Chen, Xianwei Meng, Ke Xu. ACS Appl Mater Interfaces 2020
12
16

Neutral and acidic hydrolysis reactions of the third generation anticancer drug oxaliplatin.
Maria Fatima A Lucas, Mateij Pavelka, Marta E Alberto, Nino Russo. J Phys Chem B 2009
39
16

PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features.
D Cirri, S Pillozzi, C Gabbiani, J Tricomi, G Bartoli, M Stefanini, E Michelucci, A Arcangeli, L Messori, T Marzo. Dalton Trans 2017
24
16

Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
Lucia M Balsa, Verónica Ferraresi-Curotto, Martin J Lavecchia, Gustavo A Echeverría, Oscar E Piro, Javier García-Tojal, Reinaldo Pis-Diez, Ana C González-Baró, Ignacio E León. Dalton Trans 2021
5
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.